very true, hard to understand why the FDA took such a stance that was so clearly unprofessional. It would be interesting if they would have looked at the trial data and said, "lets get you some funding and resources to fill in the gaps to get this approves ASAP", but that is not what happened. You would think given this is a pandemic the FDA would think beyond childish finger pointing.